TSX:BHC (Bausch Health Companies Inc.)

About BHC

Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), is a global, diversified pharmaceutical company enriching lives through our relentless drive to deliver better health care outcomes. We develop, manufacture and market a range of products primarily in gastroenterology, hepatology, neuroscience, dermatology, dentistry, aesthetics, international pharmaceuticals and eye health, through our controlling interest in Bausch + Lomb Corporation. Our ambition is to be a globally integrated healthcare company, trusted and valued by patients, HCPs, employees and investors.
  • Bausch Health Companies Inc. (TSX: BHC) Latest News

    The Motley Fool
    Investing

    Why Valeant Pharmaceuticals Intl Inc. Stock’s 1-Year Return of 71% Could Be Just the Beginning

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) is slowly and steadily paying down its debt with free cash flow, and it may…

    Read more »

    Investing

    3 Promising Turnaround Stocks to Consider

    Beaten-up stocks like Bombardier, Inc. (TSX:BBD.B) that have lost significant value over a short period of time can prove to…

    Read more »

    The Motley Fool
    Investing

    Which Is the Better Buy: Home Capital Group Inc. or Valeant Pharmaceuticals Intl Inc.?

    Has Home Capital Group Inc. (TSX:HCG) proven to investors that it's worth the risk?

    Read more »

    win
    Investing

    2 Stocks With Profound Market-Beating Upside

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) are compelling options for investors seeking to crush the markets over the medium to long…

    Read more »

    The Motley Fool
    Investing

    Is Valeant Pharmaceuticals Intl Inc. Still on Track?

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) continues to reduce its outstanding debt and tout new products with income potential.

    Read more »

    The Motley Fool
    Investing

    3 Drug and Nutrition Stocks That Belong in Your TFSA

    Stocks such as Jamieson Wellness Inc. (TSX:JWEL) offer the potential for explosive growth going forward.

    Read more »

    The Motley Fool
    Investing

    Can Valeant Pharmaceuticals Intl Inc. Sell its Way to Success?

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYXE:VRX) will see it revenue drop as it sells assets to pay off debt. Can it…

    Read more »

    Investing

    3 Turnaround Stocks, 3 Massive Opportunities

    BlackBerry Ltd. (TSX:BB)(NYSE:BB) and Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) have big upside remaining and good early signs of a comeback.

    Read more »

    The Motley Fool
    Investing

    Has Valeant Pharmaceuticals Intl Inc. Proven it Belongs in Your TFSA?

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) could once again be a market-beating stock, but are the risks still too high?

    Read more »

    The Motley Fool
    Investing

    New Incentive Program at Valeant Pharmaceuticals Intl Inc. Signals a New Culture That Investors Can Stand by

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) is doing the right things to regain shareholders' trust.

    Read more »

    The Motley Fool
    Investing

    Better Turnaround Stock: Valeant Pharmaceuticals Intl Inc. vs. Home Capital Group Inc.

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) has big company-specific risk due to its highly levered balance sheet, but it's attempting to…

    Read more »

    The Motley Fool
    Investing

    Valeant Pharmaceuticals Intl Inc. Q4 Earnings Review: Hold on Tight

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) beat fourth-quarter earnings estimates, but it missed on revenues.

    Read more »